NYSEARCA:NVOH Novo Nordisk A/S (B Shares) ADRhedged (NVOH) Price, Holdings, & News $30.60 +0.84 (+2.82%) As of 02:21 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatingsBuy This Stock About Novo Nordisk A/S (B Shares) ADRhedged (NYSEARCA:NVOH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NVOH alerts:Sign Up Key Stats Today's Range$29.89▼$30.6450-Day Range$24.66▼$43.6152-Week Range$24.66▼$54.13Volume8,770 shsAverage Volume1,691 shsMarket Capitalization$306 thousandAssets Under ManagementN/ADividend YieldN/ANet Expense Ratio0.19%Aggregate RatingHold ETF Overview Read More Novo Nordisk A/S (B Shares) ADRhedged ExpensesTypeNVOHSingle Stock ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.17%0.93%0.56%0.51%0.53%Other Expenses0.02%0.64%0.56%0.59%0.56%Total Expense0.19%1.35%0.76%0.74%0.73%Fee Waiver0.00%-1.01%-0.66%-0.71%-0.63%Net Expense0.19%1.03%0.63%0.58%0.60% Receive NVOH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novo Nordisk A/S (B Shares) ADRhedged and its competitors with MarketBeat's FREE daily newsletter. Email Address NVOH ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com NVOH ETF - Frequently Asked Questions How have NVOH shares performed this year? Novo Nordisk A/S (B Shares) ADRhedged's stock was trading at $34.29 at the beginning of the year. Since then, NVOH shares have decreased by 10.8% and is now trading at $30.60. How do I buy shares of Novo Nordisk A/S (B Shares) ADRhedged? Shares of NVOH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerPrecidian Funds Fund NameNovo Nordisk A/S (B Shares) ADRhedged Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:NVOH Inception Date1/2/2025 Fund ManagerDaniel McCabe, Mark Criscitello WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusSingle Stock Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$0.00 Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorPrecidian Funds, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares10,000BetaN/A Creation Unit25,000 Creation Fee$250.00 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Top 6 NVOH HoldingsU.S. DollarHolding Weight: 193.02%Novo Nordisk A/S (NYSE:NVO)Holding Weight: 99.79%Danish KroneHolding Weight: 94.46%Dreyfus Trsry Securities Cash MgmtHolding Weight: 0.47%Danish KroneHolding Weight: -94.46%U.S. DollarHolding Weight: -193.27%Full Holdings Details This page (NYSEARCA:NVOH) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S (B Shares) ADRhedged Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S (B Shares) ADRhedged With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access